Integrated provider of medical cannabis operating under the brands ENUA and SLOUU; reported 2025 revenue above 50,000,000 EUR, ~15 tonnes of product moved in 2025 and double-digit EBITDA margin. Plans international expansion (UK Q1 2026, Poland end of 2026) and further vertical integration.